Avid Bioservices Inc (CDMO)

[pphmtoolong]

If Peregrine management is judged by what they have achieved over the last few years, they deserve very high marks. Focusing on Bavi. Salvaging the NSCLC trial messed up by those idiots in Fargo. Expanding Avid. Moving Bavi strongly into the immune-oncology world. Funding through the convertible shares. Etc. Anyone who slams management ignores a very substantial record of accomplishment.

Of course, the solid negative fact they focus on is the lousy share price. Conceded, the share price sucks.

However, if the Sunrise trial, the Bavi-Yervoy trial, and other efforts are successful, the share price will come around one way or another. In fact those of us who buy at these prices could make a very large profit.

We will know in the next months, I'd guess six months, which way Peregrine will go. To the penthouse or the outhouse.

GLTA, Paul